Pharmaceuticals

Fighting Diseases

Latest News
August 04, 2022
Second quarter of 2022
Bayer: Strong growth, outlook raised
July 14, 2022
Not intended for U.S. and UK Media
Bayer to sell men’s health product Nebido™ to Grünenthal
June 30, 2022
Not intended for U.S. and UK Media
Kerendia™ (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes